12 Health Care Stocks Moving In Thursday's Intraday Session
GainersLucy Scientific Discovery (NASDAQ:LSDI) shares moved upwards by 205.8% to $1.56 during Thursday's regular session. The company's market cap stands at $2.7 million. SINTX Techs (NASDAQ:SINT) sha
NRX Pharmaceuticals Eyes $30M Refinancing and Funding Deal
Earnings Call Summary | NRX Pharmaceuticals(NRXP.US) Q1 2024 Earnings Conference
The following is a summary of the NRx Pharmaceuticals, Inc. (NRXP) Q1 2024 Earnings Call Transcript:Financial Performance:NRx Pharmaceuticals reported a Q1 2024 net loss of $6.5 million, a reduction o
Express News | NRX Pharmaceuticals Q1 EPS $(0.74) Misses $(0.37) Estimate
10-Q: Quarterly report
NRX Pharmaceuticals 1Q Loss $6.5M >NRXP
NRX Pharmaceuticals 1Q Loss $6.5M >NRXP
Express News | NRX Pharmaceuticals (Nasdaq:Nrxp) Reports First Quarter 2024 Financial Results and Provides Business Update
Notable Earnings After Tuesday's Close
Express News | NRX Pharmaceuticals Inc: Eyes First Commercial Revenue in 2024
NRx Pharmaceuticals Eyes First Commercial Revenue in 2024, Announces Breakthroughs in Bi-Annual Milestone Update
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it...
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Report First Quarter 2024 Financial Results on May 14, 2024
RADNOR, Pa., May 7, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it will rele
NRx Pharmaceuticals Shares Rise 38% After Positive Drug Trial Data
By Chris Wack NRx Pharmaceuticals shares were up 38% to $2.90 after the company said it saw a statistically significant safety advantage of NRX-101 compared to the standard of care comparator in its
12 Health Care Stocks Moving In Monday's Intraday Session
GainersNRX Pharmaceuticals (NASDAQ:NRXP) shares increased by 39.5% to $2.93 during Monday's regular session. The company's market cap stands at $30.9 million. TC BioPharm (Holdings) (NASDAQ:TCBP) stoc
NRx Pharmaceuticals Plans To Seek Accelerated Approval Of NRX-101 - Quick Facts
NRx Pharmaceuticals Climbs on Positive Results From Its Bipolar Depression Treatment Trial
NRx Pharmaceuticals (NASDAQ:NRXP) shares rise about 5% premarket after the company announced a statistically significant safety advantage of NRX-101 compared to the standard of care comparator in its recently completed clinical trial in patients with suicidal bipolar depression.
Express News | NRx Pharmaceuticals Announces Final Clinical Trial Results; Believes Demonstration Of Reduced Akathisia In Setting Of Comparable Antidepressant Efficacy Constitutes Basis For Accelerated FDA Approval Of Nrx-101
Express News | NRX Pharmaceuticals Inc - Statistically Significant Safety Advantage of NRX-101 Compared to Standard of Care
Express News | NRX Pharmaceuticals Inc - Company Plans to Seek Accelerated Approval of NRX-101 for Use in Patients With Bipolar Depression at Risk of Akathisia
Express News | NRX Pharmaceuticals Inc - NRX-101 Demonstrated a Mean 76% Reduction in Symptoms of Akathisia Compared to Lurasidone